CPTX2309
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CPTX2309, covering 2026-04-01 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE) [Phase 1]